Treatment of HIV disease in 1993/1994.
Fischl
M A
MA
University of Miami School of Medicine, Florida.
D016049:Didanosine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018119:Stavudine / Q000009:adverse effects / Q000627:therapeutic use; D016047:Zalcitabine / Q000009:adverse effects / Q000627:therapeutic use; D015215:Zidovudine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D015224:Dideoxynucleosides; D015215:Zidovudine; D016047:Zalcitabine; D018119:Stavudine; D016049:Didanosine